Observational study of people infected with SARS-Cov-2, treated with amantadine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Observational study of people infected with SARS-Cov-2, treated with amantadine
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-11
DOI
10.1007/s43440-020-00168-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study
- (2020) Olivier Rascol et al. DRUGS & AGING
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
- (2020) Virginia D. Schmith et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Amantadine Treatment for People with COVID-19
- (2020) Ramiro Araújo et al. ARCHIVES OF MEDICAL RESEARCH
- The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2
- (2020) Rolf F. Barth et al. Diagnostic Pathology
- Use of amantadine in a patient with SARS‐CoV‐2
- (2020) Gonzalo Emiliano Aranda‐Abreu et al. JOURNAL OF MEDICAL VIROLOGY
- Amantadine as a drug to mitigate the effects of COVID-19
- (2020) Gonzalo Emiliano Aranda Abreu et al. MEDICAL HYPOTHESES
- Does amantadine have a protective effect against COVID-19?
- (2020) Albert Cortés Borra Neurologia i Neurochirurgia Polska
- Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
- (2020) Konrad Rejdak et al. Multiple Sclerosis and Related Disorders
- Azithromycin, the Holy Grail to Prevent Exacerbations in Chronic Respiratory Disease
- (2019) Tobias Welte AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antiviral amantadine
- (2019) Taha Nisar et al. LANCET NEUROLOGY
- Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling
- (2018) Fahad Al-Rashed et al. Scientific Reports
- Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
- (2016) Jennifer L. McKimm-Breschkin et al. ANTIVIRAL RESEARCH
- Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis
- (2015) Paul E. Marik et al. PLoS One
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
- (2010) Agnes E. Coutinho et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
- (2009) Magali Meyer et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
- (2008) Erik von Elm et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now